Cargando…
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
COVID-19 is a highly transmissible disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), affects 226 countries and continents, and has resulted in >6.2 million deaths worldwide. Despite the efforts of all scientific institutions worldwide to identify potential therapeuti...
Autores principales: | Panda, Mamta, Kalita, Elora, Singh, Satyendra, Kumar, Ketan, Rao, Abhishek, Prajapati, Vijay Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249409/ https://www.ncbi.nlm.nih.gov/pubmed/35787998 http://dx.doi.org/10.1016/j.lfs.2022.120761 |
Ejemplares similares
-
Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics
por: Panda, Mamta, et al.
Publicado: (2022) -
Translational vaccinomics and structural filtration algorithm to device multiepitope vaccine for catastrophic monkeypox virus
por: Singh, Satyendra, et al.
Publicado: (2023) -
Identification of multi-targeting natural antiviral peptides to impede SARS-CoV-2 infection
por: Singh, Satyendra, et al.
Publicado: (2022) -
Differential Expression of miRNA Regulates T Cell Differentiation and Plasticity During Visceral Leishmaniasis Infection
por: Pandey, Rajan Kumar, et al.
Publicado: (2016) -
Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections
por: Ojha, Rupal, et al.
Publicado: (2023)